Giulia Bianchi

11.9k citations
132 papers · 6.5k · 4 hit papers · h-index 32

Impact in

  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology
    • Peptidase Inhibition and Analysis
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

    • HER2/EGFR in Cancer Research 32
    • Cancer Treatment and Pharmacology 23
    • Lung Cancer Research Studies 7
    • Cancer Cells and Metastasis 6
    • Advanced Breast Cancer Therapies 23

Giulia Bianchi

123 papers receiving 6.3k citations

Giulia Bianchi's Hit Papers

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival 2021 · 174 citations
1740+5+11Years since publication50010001.5k

Peers

Giulia Bianchi
Comparison fields: 5 of 110
  • Oncology 4.0k
  • Cancer Research 1.7k
  • Radiology, Nuclear Medicine and Imaging 1.4k
  • Pulmonary and Respiratory Medicine 1.3k
  • Genetics 303
Replace Gilles Romieu with:
Gilles Romieu France
Irene Kuter United States
Edith A. Perez United States
Marc Espié France
Emma Clark United Kingdom
Arlene Chan Australia
Valentina Nekljudova Germany
Priya Rastogi United States
Holger Eidtmann Germany
William Jacot France
Giulia Bianchi relative to Gilles Romieu France Gilles Romieu's profile →
Citations per field
00.5×3.1×
Gilles Romieu · 1×
Citations per year

Countries citing papers authored by Giulia Bianchi

Since Specialization
Citations

This map shows the geographic impact of Giulia Bianchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Bianchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Bianchi more than expected).

Fields of papers citing papers by Giulia Bianchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Bianchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Bianchi. The network helps show where Giulia Bianchi may publish in the future.

Co-authors

The 25 scholars most cited alongside Giulia Bianchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Giulia Bianchi Line = papers co-authored together Giulia Bianchi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
Hit paper breakdown →
20111629
2
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
Hit paper breakdown →
2016582
3
Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
Hit paper breakdown →
2009517
4 2010484
5 2013316
6 2007206
7 2010199
8 2012188
9
Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival
Hit paper breakdown →
2021174
10 2019165
11 2005131
12 201597
13 200993
14 202187
15 202184
16 201779
17 201363
18 201959
19 202148
20 201846

About Giulia Bianchi

Giulia Bianchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 132 papers that have together received 6.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (32 papers), Cancer Treatment and Pharmacology (23 papers), Advanced Breast Cancer Therapies (23 papers), Breast Cancer Treatment Studies (22 papers), Cancer Genomics and Diagnostics (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Lung Cancer Research Studies (7 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Oncology (4.0k citations), Cancer Research (1.7k citations), Radiology, Nuclear Medicine and Imaging (1.4k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Genetics (303 citations). Giulia Bianchi has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Luca Gianni, Graham Ross, Semiglazov Vf, Aňa Lluch, Pinuccia Valagussa, Tadeusz Pieńkowski, Ling‐Ming Tseng, Young‐Hyuck Im, Seock‐Ah Im and Brigitte Poirier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Clinical Breast Cancer and The Breast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact